These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4873894)
21. [The skeleton structure of a hallucinogenic molecule]. Smythies JR Vestn Akad Med Nauk SSSR; 1969; 24(4):41-4. PubMed ID: 5346215 [No Abstract] [Full Text] [Related]
22. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)]. Stanciu E; Csiky K; Rácz E Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389 [No Abstract] [Full Text] [Related]
23. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. Potkin SG; Wyatt RJ; Karoum F Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842 [No Abstract] [Full Text] [Related]
24. Methylated psychotogens in the urine of psychiatric patients. Kanabus P; Krysa G; Matsumoto H; Stencka K Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608 [No Abstract] [Full Text] [Related]
25. 3,4-DMPEA and schizophrenia. Abrams R; Stabenau JR Am J Psychiatry; 1971 Apr; 127(10):1421. PubMed ID: 5549944 [No Abstract] [Full Text] [Related]
26. Mauve spot and schizophrenia. Ellman GL; Jones RT; Rychert RC Am J Psychiatry; 1968 Dec; 125(6):849-51. PubMed ID: 5698458 [No Abstract] [Full Text] [Related]
27. The metabolism of dimethoxyphenethylamine, a compound found in the urine of schizophrenics. Schweitzer JW; Friedhoff AJ Am J Psychiatry; 1968 Mar; 124(9):1249-53. PubMed ID: 5637912 [No Abstract] [Full Text] [Related]
28. Time study of the urinary excretion of 3,4-dimethoxyphenylethylamine and 3,4-dimethoxyphenylacetic acid by schizophrenic and normal individuals. Vogel WH; Ahlberg CD; Horwitt MK Int J Neuropsychiatry; 1967 Jun; 3(3):292-7. PubMed ID: 6034737 [No Abstract] [Full Text] [Related]
29. The pink spot: a red herring? Lancet; 1966 Oct; 2(7468):848-9. PubMed ID: 4162179 [No Abstract] [Full Text] [Related]
30. The schizophrenia syndrome. Examples of biological tools for subclassification. Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783 [TBL] [Abstract][Full Text] [Related]
31. 3,4-dimethoxyphenylethylamine in schizophrenia. Williams CH; Gibson JG; McCormick WO Nature; 1966 Sep; 211(5054):1195. PubMed ID: 6008085 [No Abstract] [Full Text] [Related]
32. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"]. Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A Encephale; 1969; 58(4):360-76. PubMed ID: 5378191 [No Abstract] [Full Text] [Related]
33. The "pink spot," 3,4-dimethoxyphenylethylamine, common tea, and schizophrenia. Stabenau JR; Creveling CR; Daly J Am J Psychiatry; 1970 Nov; 127(5):611-6. PubMed ID: 5491537 [No Abstract] [Full Text] [Related]
34. Pink spot and DMPEA. Ridges AP Am J Psychiatry; 1971 Jul; 128(1):122-3. PubMed ID: 5155615 [No Abstract] [Full Text] [Related]
35. The identity of the so-called pink spot in schizophrenia and Parkinson's disease. Heslinga FJ; van Tilburg W; Stam FC Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324 [No Abstract] [Full Text] [Related]
36. Pink spot as an indicator of prognosis in schizophrenia. Price J; Ridges AP; Bourdillon RE; Harper P Acta Psychiatr Scand; 1967; 43(4):424-31. PubMed ID: 5582393 [No Abstract] [Full Text] [Related]
37. Schizophrenia: evidence for the major gene hypothesis. Elston RC; Campbell MA Behav Genet; 1970 Feb; 1(1):3-10. PubMed ID: 5527371 [No Abstract] [Full Text] [Related]